A Review on Topical Emulgel
Vaibhav S. Jadhav*, Vishwajeet G. Thorat, Priyanka V. Gawali ,
Dr. Balmukund R. Rathi
SGSPS Institute of Pharmacy, Kaulkhed
Akola, Maharashtra: 444001, India..
Correspondence: vaibhavpatil30078@gmail.com
|
Article Information
|
|
Abstract
|
|
Review Article
Received: 28/11/2024
Accepted: 12/12/2024
Published: 01/01/2025
Keywords
Topical drug delivery; Emulgel;
Gelling agent; Emulsifying agent etc.
|
|
Topical
drug delivery refers to the administration of medications via the skin,
vagina, eyes, and throat to any part of the body. Drugs might be administered
for systemic or local effects. It is possible to create topical formulations
with different physicochemical characteristics, such as liquid, semisolid, or
solid. Making a medication emulsion and adding it to an emulgel creates the
topical system. A surfactant and a co-surfactant are combined to create
Emulgel, a thermodynamically stable formulation with low interfacial tension
that has various advantages, including improved permeability and strong
thermodynamic stability. These are either water
in oil emulsions or oil in water emulsions, by combining it with a gelling
agent, it became gelled. Incorporation of an emulsion into a product. It
becomes a dual-control release system to the gel, which also improves its
stabilityEmulgels are the result of combining the terms emulsion and gel.
Emulgel exhibits both a continuous release pattern and dual control. Emulgel
increases patient compliance and bioavailability. The medication content,
stability analysis, skin irritation test, pH, viscosity, particle size, zeta
potential, and other properties of the
prepared formulation are evaluated.
|
INTRODUCTION
Treating local and general conditions
can be done easily with topical pharmaceutical administration. One new area of
dermatological pharmacology is the direct accessibility of the skin as an organ
for diagnosis and treatment. The ability to deliver a large quantity of
medication to a particular area, the avoidance of gastrointestinal
incompatibility, and the avoidance of metabolic degradation linked to oral
administration are only a few benefits of topical drug delivery systems. Many
topical therapies offer better bioavailability by preventing the liver's first
pass metabolism and guaranteeing consistent distribution over an extended
period of time. The main disadvantages of topical dose forms are drug
dissolution and diffusion in hydrophobic medication delivery and drug
penetration through the stratum corneum in hydrophilic medication
administration. When creating emulgel, both oil-in-waterAdditionally,
water-in-oil emulsions are frequently used as carriers to administer
hydrophilic and hydrophobic drugs to the skin. They are also effective at
penetrating skin and dissolving medications(1,2).
Focusing on emulgel is both
fascinating and challenging because it is a novel area for topical medicine
administration with few commercialized solutions to date. Understanding the
advantages of emulsion and gel for topical drug administration is crucial
before advancing to emulgel. With the aid of an emulsifying agent, one of the
two immiscible phases of an emulsion—an internal or discontinuous phase—is
disseminated into the other (an exterior or discontinuous phase). Emulsions are
controlled-release systems. To provide a controlled effect, the drug particle
that was trapped in the internal phase passes through the outer phase and then
absorbs gently into the skin. Emulsions can be either water-in-oil or
oil-in-water. According to USP, a gel is a semisolid system that is made up of
liquid that has interpenetrated it. mixtures of big organic molecules or tiny
inorganic particles. The gel contains a greater amount of aqueous or
hydroalcoholic liquid in a cross-connected network of colloidal solid
particles, which traps tiny drug particles and maintains controlled drug
release(3,4,5).
Advantages(5,6)-
·
Drugs that
are hydrophobic are included
·
Improved
loading capacity and stability.
·
Controlled
release is a term used to describe when something is released in a controlled
manner
·
There will be
no intensive sonication.
·
Avoiding the
first-pass metabolic process
·
Keeping
gastrointestinal incompatibility to a minimum
·
More focused
on a single location.
·
Patient
compliance has improved.
Disadvantages(5,6)-
·
Contact
dermatitis causes skin irritation
·
Allergic
reactions are a possibility
·
Some
medications have a low permeability through the skin.
Types of emulgel (2,6,7,8)
Microemulsion
Microemulsions are isotropic mixtures of a
biphasic o/w systemic stabilized with a surfactant that is thermodynamically
stable and optically clear. Droplets vary in size from 10 to 100nm and do not
coalesce. It is made up of specific amounts of oil, co-surfactant, surfactant,
and water. Microemulsions may have unique properties, including extremely
low interfacial tension, a broad interfacial region, and the ability to
dissolve both aqueous and oil-soluble compounds. The ingredients in
microemulsion could help the drug permeate faster by lowering the stratum
corneum’s diffusion barrier.
However, because of their low viscosity, the
use of microemulsions in the pharmaceutical industry is limited due to their
low skin retention ability. To address this limitation, gelling agents like
HPMC K100M, Carbopol 940, and guar gum are added to the microemulsion to form
microemulsion-based gels with a viscosity appropriate for topical
application .
Nanoemulgel
Nanoemulsion is transparent (translucent)
oil-water dispersions that are thermodynamically stable due to surfactant and
cosurfactant molecules with a globule size range from 1nm to100 nm. When the
emulsion is mixed with gel, the term Nanoemulgel is used. Many drugs
have higher transdermal permeation with Nanoemulsion than with traditional
formulations such as emulsions and gels. The Nanoemulsion possesses enhanced transdermal
and dermal delivery properties in vivo as well as in vitro. Because of its high
loading capacity and small globule size, the drug easily penetrates the
skin and provides less therapeutic effect in a short period.
Macroemulsion gel
Emulgel with emulsion droplet particle sizes
greater than 400nm. They are physically invisible, but under a microscope, the
individual droplets can be seen clearly. Macroemulsions are thermodynamically
unstable, but surface-active agents can help to stabilize them.
Components
of emulgel (10,11,12)
Oils are used as
an oil phase to prepare an emulsion. Mineral oil and soft or hard
paraffin are commonly used, either alone or in combination, in topically
applied emulsions.Example: castor and mineral oils, which have laxative
effects, are the most commonly used oils for oral and topical
preparations .
Vehicles
In the emulgel
preparation, oily and aqueous vehicles are used, and both hydrophobic and
hydrophilic drugs are used.Examples of vehicles such as alcohol, water, and
other aqueous materials are used in aqueous phase emulsions .
Emulsifiers
To improve
shelf-life stability, an emulsifier is used to increase the emulsification of
the preparation. Examples of emulsifying agents are Tween 80, Span80, Tween 20,
stearic acid, etc .
Gelling
agent
Gelling agents are
used for preparing gels for any dosage form. It enhances the consistency of any
formulation. Some examples of gelling agents are Carbopol 940, Carbopol 934,
HPMC-2910, etc(17) .
pH
adjusting agent
These agents are
used to maintain the pH of the formulation. Example: triethylamine, NaOH, etc.
Preparation
of emulgel (15,18,)
Step
1: Formulation of gel base
The gel base is
formed by dissolving a known quantity of polymer into DDW by mixing at moderate
speed using a magnetic stirrer and pH is adjusted to 5-6.5 using
Triethanolamine and NaOH .
Step
2: Formulation of O/W or W/O type of emulsion
Formulation of
Smix in the appropriate ratio using a magnetic stirrer. Add the Smix into the
oil phase dropwise under continuous stirring, which gives a clear emulsion(19) .
Step
3: Formulation of emulgel- Add the prepared
emulsion into gel base dropwise with continuous stirring using a homogenizer to
get emulgel.
Table 1: Marketed formulation of emulgel (20,22)
|
Sr. No.
|
Marketed formulation
|
API
|
Manufacturer
|
Use
|
|
1.
|
Diclobar
emulgel
|
Diclofenac
diethyl amine
|
Barakat
Pharma
|
Anti-inflammatory,
analgesic
|
|
2.
|
Voltaren emulgel
|
Diclofenac diethyl
ammonium
|
Novartis Pharma
|
Anti-inflammatory
|
|
3.
|
Miconaz-H-emulgel
|
Miconazole
nitrate, Hydrocortisone
|
Medical
union Pharmaceuticals
|
Topical
corticosteroid and antifungal
|
|
4.
|
Diclomax emulgel
|
Diclofenac sodium
|
Torrent Pharma
|
Anti-inflammatory
|
|
5.
|
Levorag
emulgel
|
Hibiscus,
licorice, natural extracts
|
THD
Ltd.
|
Emollient
|
Evaluation
Parameters of Emulgel
1)
Physical
Appearance (23) -
Color, homogeneity, consistency, and
pH of the produced Emulsion compositions were visually evaluated.
2)
Spreadability(23,24,25)
-
Spreadability is measured using this method based on the emulgel's
'Slip' and 'Drag' qualities. On this block a ground glass slide is fixed. This
ground slide has an excess of emulgel
(approximately 2 gm) under observation.
After that, the emulgel is placed between this slide and a second
glass slide with the same size as the
fixed ground slide, as well as a hook. For 5 minutes, a 1 kg weight is placed
on top of the two slides to release air
and provide a consistent emulgel coating between the slides. The excess emulgel
is scraped away from the edges. After
that, an 80-gram pull is applied to
the top plate. The time (in seconds) required by the top slide to cover a distance of 7.5 cm should be recorded
with the help of string tied to the hook. The shorter interval, the better the spreadability.
The formula was used to calculate spreadability.
S= M.L/T
Where,
S = spreadability.
M = Weight tied to upper
slide.
L = Length of glass
slides.
T = Time taken to detach
the slides
3)
Extrudability
study(24,26)-
To
find out how much force is needed to extrude material from a tube, this
empirical test is frequently used. The process for figuring out how much
applied shear in the rheogram zone causes plug flow when the shear rate is higher
than the yield value. The percentage of emulgel and emulgel extruded from a
lacquered aluminum collapsible utilizing the gramme weight needed to extrude at
least a 0.5 cm emulgel ribbon in 10 seconds is the basis for the extrudability
evaluation of emulgel formulations in this study. As the amount extruded rises,
extrudability gets better. The extrudability of each formulation is measured
three times, and the average results are shown. The extrudability is then
calculated using the following formula:
Extrudability = Weight used to extrude emulgel from tube (in
gm) / Area (in cm2)
4) Rheological studies(24)
–
A
Brookfield viscometer with spindle no.18
at 100 rpm is used to
determine the rheological
properties of the various emulgel compositions at 250○ C.
5)
Swelling
Index(27,28) –
The swelling index was
calculated by weighing 1 gramme of prepared topical emulgel on porous aluminium
foil and placing it individually, undisturbed, in a 50 ml glass beaker with 10
ml of 0.1 N NaOH. After that, the samples are taken out of the beakers at
different intervals and left in a dry location for a while before being weighed
again. The following formula was used to determine the swelling index:
SW % =
[Wt – Wo / Wo] × 100
Where,
SW % =
Equilibrium percent swelling,
Wt =
Swollen Weight emulgel after time t,
Wo =
Initial weight of emulgel at time zero
6)
Skin irritation test (28)
Skin irritation test is usually done in skin of human volunteers
with proper written consent. The prepared formulation is applied to the skin of
the hand and observation is done to check for any undesirable effects
7) Stability study (29)–
The emulgels are packed
in aluminium collapsible tubes (15
gramme) and tested for three
months at 50°C, 250°C/60 percent relative
humidity, 300°C/65 percent
relative humidity, and
400°C/75 percent relative
humidity. Each month, samples are taken and evaluated
according to ICH requirements for physical appearance, pH, rheological
properties, drug content, and drug release profile, among other things
8)
Dilution test(29)
–
By introducing Continuous phase to a 50 to 100
times aqueous dilution of emulgel, phase separation and clearness were
visually verified.
9)
pH measurement(30)
A digital pH meter is used to determine the pH of all prepared
emulgel. Calibration of the pH meter is performed before using a standard
buffer solution. 1 gm of the formulation is dissolved in distilled water until
a uniform suspension is formed and is kept aside for 2 hours. After 2 hours the
glass electrode is dipped in the suspension and the pH is measured
10) In Vitro release study(31,32,33) –
The
Franz diffusion cell is used to perform the drug release studies. Emulgel is
applied uniformly throughout the egg membrane. The egg membrane is anchored
between the donor and the receptor chamber of the diffusion cell. Next, freshly
prepared PBS (pH 5.5) solution is added to the receptor chamber in order to
solubilize the drug. The receptor chamber is stirred using a magnetic stirrer.
A UV visible spectrophotometer must be used to evaluate the drug content of the
appropriately diluted samples after the 1.0 ml aliquots of the emulgels have
been collected at the proper intervals. The total amount of medication released
at each time period is calculated using cumulative adjustments. Time is used as
a function to determine how much medication is released overall the egg
membrane.
CONCLUSION
Emulgels' advantages in
spreadability, adhesion, viscosity, and extrusion will make them a popular drug
delivery method.The widespread usage of topical medicine delivery devices is
due to increased patient compliance. They will also be used to load hydrophobic
medications onto gel bases that dissolve in water.
REFERENCES
1. Das
S K, Khanum A, Ghosh A. Microemulsion based gel Technique- A Novel Approach for
Sustained Delivery to Treat Fungal Infection. Indo American Journal of Pharmaceutical Research, 2019; 8(2):
1958.
2
Kumar N, Saxena C, A Novel Approach for
Topical Drug Delivery System -Emulgel
Trends in Pharmaceutical and
Nanotechnology, 2019; 1(2):
27-28.
3
Mathew N J, Mathew F, Eldhouse M P, “Emulgel-
A Formulation for Topical Delivery of Hydrophobic Drugs, International Journal of
Universal Pharmacy and BioScience, 2016; 102-114.
4
Ashara K C, Paun J S, Soniwala M M,
Chavada J R, Mori N M, “Micro- Emulgel based Emulgel: A Novel Topical Drug
Delivery System, Asian Pacific Journal
of Tropical Disease, 2014: S28.
5
Panwar A S, Jain D K. Emulgel; A Review.Asian Journal of Pharmacy and Life Science,
2011;1:336-337.
6
Sah S K, Badola A, Nayak B K. Emulgel:
Magnifying the application of topical drug delivery. Indian Journal of Pharmaceutical andBiological Research, 2017; 5(1):25-33.
7
Arora R, Khan R, Ojha A, Upadhyaya K,
Chopra H. Emulgel- A Novel Approach for Hydrophobic Drugs International
Journal of Pharmacy and Biological
Science, 2017; 7(3):43-45.
8
Yogi J, Dabhi V, Chaudhary S, Shah H,
Sanghvi K. Microemulsion as Advance Topical Drug Delivery: A Review. International Journal of Pharmaceutical Research and Bioscience, 2015;
4(1):321-322.
9
Sreevidya V S. An Overview on Emulgel. International Journal of Pharmaceutical and
Phytopharmacological Research, 2019; 9(1):93-94.
10 Light
k, Karboune S. Emulsion, hydrogel and Emulgel system and novel application in
cannabinoid delivery: a review. Taylor & Francis Group. 2021; 22:1-31.
11 Mohammed
Haneefa P K. Emulgel: An Advance Review. Journal
of Pharmaceutical Science and Research,
2013; 5(12):254-258.
12 Satya
Lakshmi S, Divya R, Srinivasa Rao Y, Kamala Kumari PV, Deepthi K. Emulgel-Novel
Trend in Topical Drug Delivery System – Review Article. Research J. Pharm. and Tech. 2021; 14(5): 2903-2906.
13 Sharma
A K, Tarun Garg, Goyal A K, Rath G. Role of microemulsion in advance drug
delivery. Informa healthcar e2014;
4: 1177-1185.
14 Anand
K, Ray S, Rahman M, Shaharya M A, Bhowmik R, Bera R. Nano-Emulgel: Emerging as
a Smarter Topical Lipidic Emulsion-based Nanocarrier for Skin Healthcare
Applications. Recent Patents on
Anti-Infective Drug Discovery. 2019; 14(1): 16-35.
15 Hyma
P, Jahan N, Raheemunissa, Sreelekha G, Babu K. Emulgel: A Review. International Journal of Pharmaceutical Archive. 2014; 2(3): 459-467.
16 Yadav
S K, Mishra M k, Tiwari A, Shukla A, ‘Emulgel: A New Approach for Enhanced
Topical Drug Delivery, 2017; 9(1):
15.
17 Jain
S K, Bajapi P, Modi S K, Gupta P, ‘A Review on Emulgel, as a Novel Trend in
Topical Drug Delivery’, Recent Trends in Pharmaceutical Sciences and Research, MAT Journal, 2019; 1(2): 31-21.
18 Singh
R P, Parpani S, Narke R, Chavan N R, ‘Emulgel: A Recent Approach for Topical
Drug delivery System’, Asian Journal
of Pharmaceutical Research and
Development, 2014; 2:
114.
19 Khare
S, Abyankar S. Kuchekar A, Gawade A, A Mini Review - Pharmaceutical Creams, Sch Acad J Pharm, 2021; 10(04):
60-62.
20 Dhawas
V, Dhabarde D, Patil S, Emulgel: A Comprehensive Review for Novel Topical Drug
Delivery System, International Journal
of Recent Scientific Research, 2020;
11(04): 38135-38136.
21 Sanjay,
Jain BD, Padsalg A, Patel K, Mokale V, Formulation, development, and evaluation
of Fluconazole gel in various polymer bases, Asian. J. Pharma, 2007;
(1); 63-69.
22 Charyulu
N R, et al, Emulgel: A Boon for Enhanced Topical Drug Delivery, J Young Pharm, 2021; 13(1):
76-79.
23 Gousia
B S et al, A Review on Emulgels-A Novel Approach for Topical Drug Delivery, Asian Journal of Pharmaceutical Research and
Development, 2019; 7(2): 70-77.
24 Kegade
P et al, Emulgel: In Treatment of Periodontitis, World Journal of Advance Healthcare
Research, 2020, 4(5):
71-75.
25 Kumar
D, Singh J, Antil M, Kumar V, Emulgel- Novel Topical Drug Delivery System–A
Comprehensive Review, International
Journal of Pharmaceutical
Science and Research, 2016; 7(12):
4735.
26 Manmode
P D et al, Formulation and Evaluation of Flurbiprofen Emulgel by Using Natural
Permeation Enhancers, 2021; 10(1):
827-828.
27 Baibhav
J et al, Emulgel: A Comprehensive Review on the Recent Advances in Topical Drug
Delivery, International Research
Journal of Pharmacy, 2011;
2(11): 66-70.
28 Ojha
A, Ojha M, Satheesh Madhav N V, ‘Recent Advancement in Emulgel: A Novel
Approach for Topical Drug Delivery, International
Journal of Advances in
Pharmaceutics, 2017; 21.
29 Ambhore
N P, Dandagi P M, Gadad A P, Mandora P, ‘Formulation and Characterization of
Tapentadol Loaded Emulgel for Topical Application, Indian Journal of Pharmaceutical Education and Research, 2017; 51(4): 527-529.
30 Rode
R J et al, A Comprehensive review on Emulgel: A New Approach for Enhanced
Topical Drug Delivery, International
Journal of Modern Pharmaceutical
Research, 2021; 5(3):
222-233.
31 Goyani
M et al, Formulation and Evaluation o Topical Emulgel of Antiacne Agent, International Journal of Advanced Research and Review, 2018; 3(7): 52-68.
32 Jain
A, Gautam S P, Gupta Y, Khambete H, Jain S, Development and characterization of
ketoconazole emulgel for topical drug delivery, Pelagia Research Library Der, 2010; 1(3): 221-231.
33 Anand
K et al, Nano-emulgel: Emerging as a Smarter Topical Lipidic Emulsion-based
Nanocarrier for Skin Healthcare Applications, Recent Patents on Anti-Infective Drug Discovery, 2019; 14: 16-35.
34 Jivani
M N, Patel C P, Prajapat B G, Nanoemulgel Innovative Approach for Topical Gel
Based Formulation, Research and Reviews on Healthcare: Open Access Journal, 2018: 18-22.
35 Pawbake
G R, Shirolkar S V, Microemulgel: A Promising Approach to Improve the
Therapeutic Efficacy of Drug, Journal
of Critical Reviews, 2020; 7(14):
1138-1142.